Meghmani Organics Ltd — earnings calls

Meghmani Organics reported Q1 FY27 standalone revenue of nearly INR523 crores, down 12% year-on-year, while net profit grew 42% to nearly INR58 crores and EBITDA grew 16% to about INR94 crores. Management attributed the revenue decline to softer demand across export and domestic markets and lower capacity utilization, while profitability improved through product mix optimization, pricing discipline and operational efficiencies. The Titanium Dioxide operation at Kilburn Chemicals remained suspended due to elevated sulfuric acid costs and withdrawal of anti-dumping duty, posting a negative EBITDA of nearly INR3 crores in the quarter.

Meghmani Organics reported FY26 standalone revenue of Rs 2,091 crores, up 4% year-on-year, with EBITDA growing 27% to Rs 228.7 crores, while Q4 FY26 saw margin pressure from rising raw material costs amid geopolitical tensions. Management described headwinds from U.S. tariffs and the U.S.-Iran war that softened export demand and pressured the Crop Protection and Pigments segments during the year. The company also discussed suspension of its Titanium Dioxide operations due to commercial unviability, approval for nano fertilizer products, and a proposed amalgamation of its Kilburn Chemicals and Meghmani Crop Nutrition subsidiaries into the parent company.